Clinical trialNCT06359041RecruitingPhase 1/PHASE2Interventional

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

SponsorCabaletta BioEnrollment24Generalized Myasthenia Gravis (gMG)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RESET-MG: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Participants with Generalized Myasthenia Gravis

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Medical Director
Cabaletta Bio
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California Irvine
Orange, California, United States
Ali Habib, MD
Recruiting
Uc Davis, Department of Neurology
Sacramento, California, United States
David Richman, MD
Recruiting
University of California, San Francisco
San Francisco, California, United States
Dr. Min Kang, MD
Recruiting
University of Colorado
Aurora, Colorado, United States
Amanda Piquet, MD
Recruiting
Mayo Clinic Florida
Jacksonville, Florida, United States
Dr. Jaimin Shah, MD
Recruiting
Northwestern Memorial Hospital
Chicago, Illinois, United States
Dr. Arjun Seth, MD
Recruiting
University of Kansas Medical Center
Kansas City, Kansas, United States
Mazen Dimachkie, MD
Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Pushpa Narayanaswami, MD
Recruiting
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States
Dr. Margaret A. Owegi, DO
Recruiting
Mayo Clinic - Rochester
Rochester, Minnesota, United States
Elie Naddaf, M.D.
Recruiting
Columbia University
New York, New York, United States
Dr. Christina Ulane, MD
Recruiting
University of Rochester Medical Center
Rochester, New York, United States
Dr. Alexis Lizarraga, MD, MS
Recruiting
Oregon Health & Science University
Portland, Oregon, United States
Dr. Nizar Chahin, M.D.
Recruiting
Baylor College of Medicine Neurology Department
Houston, Texas, United States
Milvia Pleitez, MD
Recruiting
Houston Methodist Hospital
Houston, Texas, United States
Dr. Sheetal Shroff, MD
Recruiting
University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Uday Popat, MD
Recruiting
Swedish Neuroscience Research
Seattle, Washington, United States
Dr. Christyn Edmundson, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CABA-201

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Dec 2024
Primary completion: 30 Sept 2029
Completion: 30 Sept 2029
Last update posted: 13 Aug 2026
Registered enrollment: 24
Registry id: NCT06359041

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.